XOMA Royalty Corp.
NASDAQ:XOMABiotechnology
+$0.19 today
- Market cap
- $503.77M
- Beta
- 0.87
- P/E (TTM)
- 15.8
- EPS (TTM)
- $2.65
Volume 4.22M
Average 0.21M
XOMA Net Income
Bottom-line profit, the starting point for calculating cash from operations.
XOMA Royalty Corp.NASDAQ: XOMA
Net Income · Q1 FY2026 · quarter ended Mar 2026
Net income grows, but more slowly than its trailing trend
Q1 FY2026 net income of $3.57M rose 51.0% year over year, behind the +1041.4% change in trailing-twelve-month net income. Sequentially, it fell 41.5% from the prior quarter.
Context
- Net income amounted to 60.8% of revenue in FY2025, up 12.3 pp from a year earlier.
- Net income increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether net income reaches the consensus estimate from 2 analysts of $15.03M (-52.6%) for the fiscal year ending Dec 2026, a slowdown from the +329.4% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $3.57M-41.5% QoQ
- Last fiscal yearDec 2025
- $31.71M+329.4% YoY
- LTMMar 2026
- $26.92M+1041.4% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +51.0% | -55.5% | -106.4 pp |
| 1 year | +329.4% | -52.6% | -382.0 pp |
| 3-year CAGR | — | -36.6% | — |
| 5-year CAGR | -6.7% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- 31.71M USD
- Year-over-year change
- +329.4%
- 4-year CAGR
- +19.0%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 31.71M | +329.4% |
| FY2024 | 2024-12-31 | (13.82M) | +66.2% |
| FY2023 | 2023-12-31 | (40.83M) | -138.7% |
| FY2022 | 2022-12-31 | (17.1M) | -208.3% |
| FY2021 | 2021-12-31 | 15.8M | — |
Net Income vs competitors
How XOMA compares with its peers on the latest reported figures
- XOMA's LTM Mar 2026 net income of $26.92M is the 9th largest of the 10 companies compared; the peer median is $103.82M.
- Its year-over-year change of +1041.4% is the highest of 10, against a peer median of +21.3%.
- Net income amounts to 74.3% of revenue for XOMA, versus a peer median of 2959.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $288.97M | +21.3% | +24.5% | 312.1% | |
| LTM Mar 2026 | $209.38M | -18.9% | +0.2% | — | |
| LTM Mar 2026 | $191.78M | +37.3% | +26.6% | — | |
| LTM Mar 2026 | $112.39M | +18.7% | +21.8% | — | |
| LTM Mar 2026 | $103.82M | +3.1% | -8.5% | 5605.9% | |
| LTM Mar 2026 | $69.71M | +24.0% | +3.3% | — | |
| LTM Mar 2026 | $41.54M | +56.8% | +27.7% | — | |
| LTM Mar 2026 | $35.1M | +30.0% | +33.8% | — | |
| LTM Mar 2026 | $26.92M | +1041.4% | — | 74.3% | |
| LTM Mar 2026 | $26.25M | -41.9% | -7.4% | — | |
| Peer median (excluding XOMA) | $103.82M | +21.3% | +21.8% | 2959.0% | |
Competitors are the stored peer set for XOMA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 15.8M | (17.1M) | (40.83M) | (13.82M) | 31.71M |
| Depreciation & Amortization | 7K | 104K | 900K | 216K | 2.97M |
| Deferred Income Tax | 0 | 0 | 0 | (5.66M) | 103K |
| Stock-Based Compensation | 6.2M | 3.61M | 9.1M | 10.31M | 9.27M |
| Change in Working Capital | (886K) | (181K) | (3.53M) | (2.79M) | (11.37M) |
| Accounts Receivables | 1.58M | 208K | (1M) | (835K) | (2.43M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 765K | 1.85M | (523K) | 1.6M | (10.6M) |
| Other Working Capital | (3.23M) | (2.23M) | (2M) | (3.55M) | 1.65M |
| Other Non-Cash Items | 1.56M | 694K | 16.2M | (2.01M) | (29.82M) |
| Operating Cash Flow | 22.68M | (12.88M) | (18.16M) | (13.75M) | 2.87M |
| Capital Expenditures | (26.5M) | (15.25M) | (17K) | (20K) | 0 |
| Acquisitions (Net) | 0 | 0 | 0 | (1.25M) | 3.85M |
| Purchases of Investments | 0 | 0 | 0 | (3.24M) | (99K) |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (26.5M) | (4.97M) | (694K) | (23.75M) | 47.14M |
| Investing Cash Flow | (26.5M) | (20.22M) | (711K) | (28.26M) | 50.89M |
| Debt Repayment | (4.25M) | 0 | 130M | (6.9M) | (10.6M) |
| Common Stock Issued | 1.58M | 2.42M | 466K | 5.21M | 8.72M |
| Common Stock Repurchased | 0 | 0 | (148K) | (13K) | (16.04M) |
| Dividends Paid | (3.5M) | (5.47M) | (5.47M) | (5.47M) | (5.47M) |
| Other Financing Activities | (21M) | (1.4M) | (3.79M) | 1.26M | (3.07M) |
| Financing Cash Flow | 12.84M | (4.45M) | 120.59M | (11.13M) | (26.46M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 9.01M | (37.55M) | 101.72M | (53.13M) | 27.29M |
| Free Cash Flow | (3.82M) | (28.13M) | (18.18M) | (13.77M) | 2.87M |
XOMA Royalty Corp.
NASDAQ:XOMA
Intrinsic Alpha fair value
Locked
Current Price
$40.17
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.